These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 33718347)
1. Increased Tumor Immune Microenvironment CD3+ and CD20+ Lymphocytes Predict a Better Prognosis in Oral Tongue Squamous Cell Carcinoma. Sales de Sá R; Miranda Galvis M; Mariz BALA; Leite AA; Schultz L; Almeida OP; Santos-Silva AR; Pinto CAL; Vargas PA; Gollob KJ; Kowalski LP Front Cell Dev Biol; 2020; 8():622161. PubMed ID: 33718347 [No Abstract] [Full Text] [Related]
2. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics. Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471 [TBL] [Abstract][Full Text] [Related]
3. PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4 Mattox AK; Lee J; Westra WH; Pierce RH; Ghossein R; Faquin WC; Diefenbach TJ; Morris LG; Lin DT; Wirth LJ; Lefranc-Torres A; Ishida E; Chakravarty PD; Johnson L; Zeng YC; Chen H; Poznansky MC; Iyengar NM; Pai SI Cancer Res; 2017 Nov; 77(22):6365-6374. PubMed ID: 28947422 [TBL] [Abstract][Full Text] [Related]
4. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy. Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008 [TBL] [Abstract][Full Text] [Related]
5. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time. Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216 [TBL] [Abstract][Full Text] [Related]
6. Tumor-Infiltrating CD1a Ni YH; Zhang XX; Lu ZY; Huang XF; Wang ZY; Yang Y; Dong YC; Jing Y; Song Y; Hou YY; Hua ZC; Hu QG Pathol Oncol Res; 2020 Jul; 26(3):1687-1695. PubMed ID: 31606786 [TBL] [Abstract][Full Text] [Related]
9. Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence. Daroonpan P; Ouchi R; Zhang C; Nagai S; Nishii N; Kashima Y; Tsushima F; Harada H; Hamagaki M; Ikeda T; Aida J; Kaomongkolgit R; Azuma M Oral Oncol; 2023 Aug; 143():106458. PubMed ID: 37329869 [TBL] [Abstract][Full Text] [Related]
10. Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma. Wirsing AM; Ervik IK; Seppola M; Uhlin-Hansen L; Steigen SE; Hadler-Olsen E Mod Pathol; 2018 Jun; 31(6):910-922. PubMed ID: 29416107 [TBL] [Abstract][Full Text] [Related]
11. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping. Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901 [TBL] [Abstract][Full Text] [Related]
12. PD-1/PD-L1 Axis, Rather Than High-Mobility Group Alarmins or CD8+ Tumor-Infiltrating Lymphocytes, Is Associated With Survival in Head and Neck Squamous Cell Carcinoma Patients Who Received Surgical Resection. Yang F; Zeng Z; Li J; Zheng Y; Wei F; Ren X Front Oncol; 2018; 8():604. PubMed ID: 30619746 [TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor. Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257 [TBL] [Abstract][Full Text] [Related]
14. The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma. Gurin D; Slavik M; Hermanova M; Selingerova I; Kazda T; Hendrych M; Shatokhina T; Vesela M J Oral Pathol Med; 2020 Oct; 49(9):886-896. PubMed ID: 32516834 [TBL] [Abstract][Full Text] [Related]
15. Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer. De La Motte Rouge T; Corné J; Cauchois A; Le Boulch M; Poupon C; Henno S; Rioux-Leclercq N; Le Pabic E; Laviolle B; Catros V; Levêque J; Fautrel A; Le Gallo M; Legembre P; Lavoué V Mol Cancer Res; 2019 Dec; 17(12):2537-2548. PubMed ID: 31537619 [TBL] [Abstract][Full Text] [Related]
16. Tumour-Infiltrating Lymphocytes (TILs) and PD-L1 Expression Correlate with Lymph Node Metastasis, High-Grade Transformation and Shorter Metastasis-Free Survival in Patients with Acinic Cell Carcinoma (AciCC) of the Salivary Glands. Hiss S; Eckstein M; Segschneider P; Mantsopoulos K; Iro H; Hartmann A; Agaimy A; Haller F; Mueller SK Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33669038 [TBL] [Abstract][Full Text] [Related]
18. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages. Vieira T; Antoine M; Hamard C; Fallet V; Duruisseaux M; Rabbe N; Rodenas A; Cadranel J; Wislez M Lung Cancer; 2016 Aug; 98():51-58. PubMed ID: 27393506 [TBL] [Abstract][Full Text] [Related]
19. Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma. Lu J; Chen XM; Huang HR; Zhao FP; Wang F; Liu X; Li XP Head Neck; 2018 Jun; 40(6):1245-1253. PubMed ID: 29493822 [TBL] [Abstract][Full Text] [Related]